Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W Morrison

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Hematology/Oncology Clinics of North America|February 1, 1994
The genetics of breast cancerB W Morrison
The Journal of Biological Chemistry|June 15, 1992
A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesisB W Morrison, P Leder
Oncogene|December 1, 1994
neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumorsB W Morrison, P Leder
The Journal of Reproductive Medicine|October 1, 1988
The significance of atypical cervical smearsB W Morrison, E R Erickson, N Doshi, et al.
Obstetrics and Gynecology|October 8, 1999
Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trialB W Morrison, S E Daniels, P Kotey, et al.
Journal of the American Dental Association (1939)|January 6, 2001
The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trialsB W Morrison, J Fricke, J Brown, et al.
Clinical Therapeutics|August 10, 1999
Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trialB W Morrison, S Christensen, W Yuan, et al.
International Journal of Cancer|September 25, 1999
Targeting HER-2/neu for active-specific immunotherapy in a mouse model of spontaneous breast cancerD Céfaï, B W Morrison, A Sckell, et al.
The Journal of Biological Chemistry|February 3, 1995
Mat-8, a novel phospholemman-like protein expressed in human breast tumors, induces a chloride conductance in Xenopus oocytesB W Morrison, J R Moorman, G C Kowdley, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoidsF Catella-Lawson, B McAdam, B W Morrison, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Hematology/Oncology Clinics of North America|February 1, 1994
The genetics of breast cancerB W Morrison
The Journal of Biological Chemistry|June 15, 1992
A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesisB W Morrison, P Leder
Oncogene|December 1, 1994
neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumorsB W Morrison, P Leder
The Journal of Reproductive Medicine|October 1, 1988
The significance of atypical cervical smearsB W Morrison, E R Erickson, N Doshi, et al.
Obstetrics and Gynecology|October 8, 1999
Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trialB W Morrison, S E Daniels, P Kotey, et al.
Journal of the American Dental Association (1939)|January 6, 2001
The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trialsB W Morrison, J Fricke, J Brown, et al.
Clinical Therapeutics|August 10, 1999
Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trialB W Morrison, S Christensen, W Yuan, et al.
International Journal of Cancer|September 25, 1999
Targeting HER-2/neu for active-specific immunotherapy in a mouse model of spontaneous breast cancerD Céfaï, B W Morrison, A Sckell, et al.
The Journal of Biological Chemistry|February 3, 1995
Mat-8, a novel phospholemman-like protein expressed in human breast tumors, induces a chloride conductance in Xenopus oocytesB W Morrison, J R Moorman, G C Kowdley, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoidsF Catella-Lawson, B McAdam, B W Morrison, et al.
Pageof 2